Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001628280-26-029435 |
|---|---|
| Form Type | 4 |
| Filing Date | May 1, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
4,170
Total Value
$54,694.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | May 1, 2026 | Sale | 3,870 | $13.06 | $50,542.20 | 143,842 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | May 1, 2026 | Sale | 300 | $13.84 | $4,152.00 | 143,542 | Direct | โ | View Details |